Could MiniMed 770G's Approval Boost Medtronic's Diabetes ... | 合法醫療器材資訊網

2020年9月1日—TheMiniMed770Gissignificantbecauseithassmartphoneconnectivity...Medtronic'ssystemwillenablecaregiversandcarepartnerstoseeuser...firein2016whenitwonFDAapprovalfortheMiniMed670Ginsulinpump, ...

A new approval could help Medtronic cover lost ground in the diabetes market. The Dublin-based company recently received a nod from FDA for the MiniMed 770G hybrid closed-loop system.

The device is significant because it has smartphone connectivity and will be available to patients as young as 2-years-old. Medtronic’s system will enable caregivers and care partners to see user data remotely on their smartphones, with proactive in-app notices sent when sugar levels are out of range.

Medtronic said that a  clinical study of the MiniMed 670G system conducted in children two to six years of age showed an improvement in outcomes comparable to...